Here is the Result of Overzealous Healthcare Investment Bankers

Since 2008, the laxness at the FDA has helped investment bankers bring public piece of shit, early stage, biotech scandals. The vast majority of these stocks will go bankrupt, leaving investors in shambles.

Here are today’s biotech terrorist attacks on US investors.

INFI -64.9%, MESO -36.4%, KMPH -30%, RVNC -23.7%, IMGN -11.1%